Trial Profile
A prospective study investigating effect of ivabradine on arterial stiffness and sympathetic nerve activity (sympathetic overdrive) in patients with hypertension and metabolic syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Dec 2016
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary) ; Perindopril/amlodipine
- Indications Essential hypertension; Metabolic syndrome
- Focus Pharmacodynamics
- 11 Sep 2015 New trial record